Pelosi Drug Pricing Bill Advances on Party-Line Votes

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 18, 2019 at 8:12 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,024
    Likes Received:
    3
    via Two House committees on Thursday advanced on party-line votes Speaker Nancy Pelosi’s (D-CA) bill to allow for the negotiation of certain medicine prices as part of plans to bring down costs in the US.

    article source
     

  2. anonymous

    anonymous Guest

    How is this not a greater subject of conversation? Why isn't anyone talking about this on the boards? Aren't you guys worried? Lord knows I am....
     
  3. anonymous

    anonymous Guest

    Because it this was only past to show the Democrats aren’t sitting on their hands and they wanted something to campaign on during election season. This bill clearly shows that the Democrats are not interested in employment. Just leveraging drug companies for donations.
     
  4. anonymous

    anonymous Guest

    So keep drug prices unaffordable for people so you can have a job?? Get over yourself and find another career.
     
  5. anonymous

    anonymous Guest

    Interesting. I'm honestly curious how you feel about this (I'm the one who asked the original question). While pharma is certainly full of a lot of individuals that can easily transition to other industries (marketing, sales, administration, etc.), there are a LOT of very talented and highly trained individuals who can't easily just 'find another career' (research scientists, technicians, medical advisors, regulatory experts, compliance, etc.). Are you worried about how this might affect them?

    Drug affordability is certainly an issue and it should absolutely be addressed. It should target all aspects of the problem IMO, including drug makers, PBM's, and health insurers. Do you think a bill targeting only makers is the way to go? Again, I'm looking for an honest and civil discussion.
     
  6. anonymous

    anonymous Guest